Diaceutics PLC (DXRX) — Cash Flow-to-Debt Ratio
Diaceutics PLC (DXRX) has a Cash Flow-to-Debt Ratio of 0.11x as of June 2025, meaning its operating cash flow of GBX800.00K could theoretically repay 0% of its total liabilities (GBX7.18 Million) in one year. See Diaceutics PLC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Diaceutics PLC Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Diaceutics PLC across 9 annual periods. Also explore Diaceutics PLC equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Diaceutics PLC (2016–2024)
Year-by-year debt coverage analysis for Diaceutics PLC. For market capitalisation and broader financial context, see DXRX market cap.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | GBX651.00K | GBX8.76 Million | ▼ -68.5% |
| 2023 | 0.24x | GBX1.31 Million | GBX5.56 Million | ▼ -73.4% |
| 2022 | 0.89x | GBX5.10 Million | GBX5.74 Million | ▲ +579.5% |
| 2021 | 0.13x | GBX570.00K | GBX4.36 Million | ▲ +69.4% |
| 2020 | 0.08x | GBX253.00K | GBX3.28 Million | ▲ +127.5% |
| 2019 | -0.28x | GBX-627.05K | GBX2.24 Million | ▼ -52.1% |
| 2018 | -0.18x | GBX-954.04K | GBX5.18 Million | ▼ -143.4% |
| 2017 | 0.42x | GBX1.53 Million | GBX3.61 Million | ▲ +52.9% |
| 2016 | 0.28x | GBX674.01K | GBX2.43 Million | — |